Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04313725 · ClinicalTrials.gov registry record · NA
Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease
A NA study, sponsored by Tangible Science.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT04313725 is a NA study that was terminated before completion, run by Tangible Science. The registered enrollment target is 28 participants.
The verdict
NCT04313725, a NA study, was terminated before completion, sponsored by Tangible Science.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The goal of this research is to determine if the Tangible Boost system adequately replenishes the Hydra-PEG coating on the surface of a rigid contact lens. Hydra-PEG is a coating for soft and rigid contact lens, primarily composed of polyethylene glycol-based hydrogel, which is covalently bound to the surface of a contact lens. The Hydra-PEG coating is intended to improve wettability and comfort with contact lenses and is currently FDA approved on a number of contact lenses. For patients with Stevens Johnson Syndrome (SJS) (SS), or Graft versus Host disease (GVHD), diminished efficacy of the Hydra-PEG coating can lead to significant decline in satisfaction with the lenses over time. This is a prospective study to evaluate the efficacy of Tangible Boost, a monthly conditioning solution, to replenish the Hydra-PEG coating on rigid gas permeable contact lenses for patients with SJS, GVHD, and SS. Outcomes from this patient population will be compared to patients with dry eye disease.
Interventions
- OTHER Placebo
- DEVICE Tangible Boost
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2023-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04313725
The ClinicalTrials.gov registry entry for NCT04313725 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tangible Science, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04313725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04313725 about?
NCT04313725 is a clinical study titled "Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease". The goal of this research is to determine if the Tangible Boost system adequately replenishes the Hydra-PEG coating on the surface of a rigid contact lens. Hydra-PEG is a coating for soft and rigid contact lens, primarily composed of polyethylene glycol-based hydrogel, which is covalently bound to ...
What is the current status of trial NCT04313725?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2020-02-24. Estimated completion is 2023-06-21.
What interventions are being tested in trial NCT04313725?
The interventions under investigation include: Placebo (OTHER), Tangible Boost (DEVICE).
Who is sponsoring clinical trial NCT04313725?
This trial is sponsored by Tangible Science, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.